Shots: Bicycle to receive $1.7B including $30M upfront, development & commercialization milestones and royalties on sales of Bicycle based immuno-oncology therapies against multiple targets which will be commercialized by Genentech […]readmore
Tags : Bicycle Therapeutics
Nektar Therapeutics Signs a Clinical Trial Collaboration with Bristol-Myers Squibb Published: Jan 10, 2020 | Tags: Nektar Therapeutics, Signs, Clinical Trial, Collaboration, Bristol-Myers Squibb 2. Eli Lilly to Acquire Dermira for […]readmore
Shots: Cancer Research UK to get upfront in cash and equity, success-based milestones, royalties and will fund & sponsor the development of BT7401 from preclinical to the P-IIa trial. Bicycle […]readmore